Overall, we identified 40 recurrently mutated cancer drivers, including BRAF, NRAS, ARID2 and TP53, across 466 tumors within the TCGA-SKCM dataset (413,742 total mutations), among which, BRAF dominated (35) (Table S6 and Figure S9). This evidence concerns the gene TP53 and cancer.